Tandem Diabetes Care, Inc. Stock-Based Compensation
Tandem Diabetes Care, Inc. (TNDM) reported Stock-Based Compensation of $31.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- Tandem Diabetes Care, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $15.74M, a 38.61% decline year-over-year.
- Tandem Diabetes Care, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $15.66M, a 38.56% decline year-over-year.
- Tandem Diabetes Care, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $20.11M, a 28.60% decline year-over-year.
- Tandem Diabetes Care, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $21.14M, a 19.56% decline year-over-year.
- Tandem Diabetes Care, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $92.38M, a 8.88% decline from fiscal 2024.
- Tandem Diabetes Care, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $101.38M, a 15.11% increase from fiscal 2023.
- Tandem Diabetes Care, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $88.08M, a 3.72% increase from fiscal 2022.
- Tandem Diabetes Care, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $84.92M, a 39.78% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $15.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $31.40M 10-Q · filed 2026-08-06 | $51.51M derived: sum of 3 quarters · filed 2026-08-06 | $72.65M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $15.66M 10-Q · filed 2026-05-07 | $35.77M derived: sum of 2 quarters · filed 2026-05-07 | $56.91M derived: sum of 3 quarters · filed 2026-05-07 | $82.55M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $20.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $41.25M derived: sum of 2 quarters · filed 2026-02-19 | $66.89M derived: sum of 3 quarters · filed 2026-08-06 | $92.38M 10-K · filed 2026-02-19 | |||
| 2025-09-30 | $21.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $46.78M derived: sum of 2 quarters · filed 2026-08-06 | $72.27M 10-Q · filed 2025-11-06 | $100.44M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $25.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $51.13M 10-Q · filed 2026-08-06 | $79.30M derived: sum of 3 quarters · filed 2026-08-06 | $105.58M derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $25.49M 10-Q · filed 2026-05-07 | $53.66M derived: sum of 2 quarters · filed 2026-05-07 | $79.94M derived: sum of 3 quarters · filed 2026-05-07 | $104.83M derived: sum of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | $28.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $54.45M derived: sum of 2 quarters · filed 2026-02-19 | $79.34M derived: sum of 3 quarters · filed 2026-02-19 | $101.38M 10-K · filed 2026-02-19 | |||
| 2024-09-30 | $26.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $51.18M derived: sum of 2 quarters · filed 2025-11-06 | $73.22M 10-Q · filed 2025-11-06 | $95.96M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-06-30 | $24.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $46.94M 10-Q · filed 2025-08-06 | $69.68M derived: sum of 3 quarters · filed 2026-02-19 | $90.42M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2024-03-31 | $22.04M 10-Q · filed 2025-04-30 | $44.78M derived: sum of 2 quarters · filed 2026-02-19 | $65.52M derived: sum of 3 quarters · filed 2026-02-19 | $88.92M derived: sum of 4 quarters · filed 2026-02-19 | |||
| 2023-12-31 | $22.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $43.48M derived: sum of 2 quarters · filed 2026-02-19 | $66.88M derived: sum of 3 quarters · filed 2026-02-19 | $88.08M 10-K · filed 2026-02-19 | |||
| 2023-09-30 | $20.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $44.14M derived: sum of 2 quarters · filed 2024-11-06 | $65.33M 10-Q · filed 2024-11-06 | $89.78M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-06-30 | $23.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $44.59M 10-Q · filed 2024-08-01 | $69.03M derived: sum of 3 quarters · filed 2025-02-26 | $91.27M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2023-03-31 | $21.19M 10-Q · filed 2024-05-02 | $45.63M derived: sum of 2 quarters · filed 2025-02-26 | $67.87M derived: sum of 3 quarters · filed 2025-02-26 | $88.00M derived: sum of 4 quarters · filed 2025-02-26 | |||
| 2022-12-31 | $24.44M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $46.68M derived: sum of 2 quarters · filed 2025-02-26 | $66.81M derived: sum of 3 quarters · filed 2025-02-26 | $84.92M 10-K · filed 2025-02-26 | |||
| 2022-09-30 | $22.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $42.37M derived: sum of 2 quarters · filed 2023-11-01 | $60.48M 10-Q · filed 2023-11-01 | $77.58M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-06-30 | $20.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $38.24M 10-Q · filed 2023-08-03 | $55.34M derived: sum of 3 quarters · filed 2024-02-21 | $71.07M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-03-31 | $18.11M 10-Q · filed 2023-05-03 | $35.21M derived: sum of 2 quarters · filed 2024-02-21 | $50.94M derived: sum of 3 quarters · filed 2024-02-21 | $65.92M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2021-12-31 | $17.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $32.83M derived: sum of 2 quarters · filed 2024-02-21 | $47.80M derived: sum of 3 quarters · filed 2024-02-21 | $60.75M 10-K · filed 2024-02-21 | |||
| 2021-09-30 | $15.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $30.71M derived: sum of 2 quarters · filed 2022-11-02 | $43.65M 10-Q · filed 2022-11-02 | $56.96M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-06-30 | $14.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $27.92M 10-Q · filed 2022-08-03 | $41.23M derived: sum of 3 quarters · filed 2023-02-22 | $54.07M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2021-03-31 | $12.95M 10-Q · filed 2022-05-04 | $26.25M derived: sum of 2 quarters · filed 2023-02-22 | $39.09M derived: sum of 3 quarters · filed 2023-02-22 | $55.51M derived: sum of 4 quarters · filed 2023-02-22 | |||
| 2020-12-31 | $13.31M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $26.14M derived: sum of 2 quarters · filed 2023-02-22 | $42.57M derived: sum of 3 quarters · filed 2023-02-22 | $58.43M 10-K · filed 2023-02-22 | |||
| 2020-09-30 | $12.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $29.26M derived: sum of 2 quarters · filed 2021-11-03 | $45.12M 10-Q · filed 2021-11-03 | $63.81M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-06-30 | $16.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $32.29M 10-Q · filed 2021-08-04 | $50.97M derived: sum of 3 quarters · filed 2022-02-22 | $68.20M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-03-31 | $15.87M 10-Q · filed 2021-05-05 | $34.55M derived: sum of 2 quarters · filed 2022-02-22 | $51.78M derived: sum of 3 quarters · filed 2022-02-22 | $64.10M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2019-12-31 | $18.68M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $35.91M derived: sum of 2 quarters · filed 2022-02-22 | $48.24M derived: sum of 3 quarters · filed 2022-02-22 | $58.07M 10-K · filed 2022-02-22 | |||
| 2019-09-30 | $17.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $29.55M derived: sum of 2 quarters · filed 2020-11-05 | $39.39M 10-Q · filed 2020-11-05 | $49.70M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-06-30 | $12.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $22.16M 10-Q · filed 2020-07-30 | $32.47M derived: sum of 3 quarters · filed 2021-02-24 | $42.00M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2019-03-31 | $9.83M 10-Q · filed 2020-04-30 | $20.14M derived: sum of 2 quarters · filed 2021-02-24 | $29.68M derived: sum of 3 quarters · filed 2021-02-24 | $32.38M derived: sum of 4 quarters · filed 2021-02-24 | |||
| 2018-12-31 | $10.31M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $19.85M derived: sum of 2 quarters · filed 2021-02-24 | $22.54M derived: sum of 3 quarters · filed 2021-02-24 | $23.74M 10-K · filed 2021-02-24 | |||
| 2018-09-30 | $9.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $12.23M derived: sum of 2 quarters · filed 2019-11-04 | $13.43M 10-Q · filed 2019-11-04 | $15.55M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-06-30 | $2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $3.89M 10-Q · filed 2019-08-01 | $6.02M derived: sum of 3 quarters · filed 2020-02-24 | $8.41M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-03-31 | $1.19M 10-Q · filed 2019-04-30 | $3.32M derived: sum of 2 quarters · filed 2020-02-24 | $5.71M derived: sum of 3 quarters · filed 2020-02-24 | $10.86M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2017-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $4.52M derived: sum of 2 quarters · filed 2020-02-24 | $9.66M derived: sum of 3 quarters · filed 2020-02-24 | $12.63M 10-K · filed 2020-02-24 | |||
| 2017-09-30 | $2.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $7.54M derived: sum of 2 quarters · filed 2018-11-01 | $10.50M 10-Q · filed 2018-11-01 | $13.43M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-06-30 | $5.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-30 | $8.11M 10-Q · filed 2018-07-30 | $11.04M derived: sum of 3 quarters · filed 2019-02-26 | $13.94M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-03-31 | $2.96M 10-Q · filed 2018-04-26 | $5.89M derived: sum of 2 quarters · filed 2019-02-26 | $8.80M derived: sum of 3 quarters · filed 2019-02-26 | $11.82M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | $2.93M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $5.83M derived: sum of 2 quarters · filed 2019-02-26 | $8.86M derived: sum of 3 quarters · filed 2019-02-26 | $11.66M 10-K · filed 2019-02-26 | |||
| 2016-09-30 | $2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $5.93M derived: sum of 2 quarters · filed 2017-10-26 | $8.73M 10-Q · filed 2017-10-26 | $11.82M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-06-30 | $3.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $5.83M 10-Q · filed 2017-07-27 | $8.91M derived: sum of 3 quarters · filed 2018-03-01 | $11.89M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2016-03-31 | $2.80M 10-Q · filed 2017-04-27 | $5.89M derived: sum of 2 quarters · filed 2018-03-01 | $8.86M derived: sum of 3 quarters · filed 2018-03-01 | $12.12M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | $3.09M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $6.06M derived: sum of 2 quarters · filed 2018-03-01 | $9.32M derived: sum of 3 quarters · filed 2018-03-01 | $13.10M 10-K · filed 2018-03-01 | |||
| 2015-09-30 | $2.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $6.24M derived: sum of 2 quarters · filed 2016-11-01 | $10.01M 10-Q · filed 2016-11-01 | $13.96M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2015-06-30 | $3.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $7.03M 10-Q · filed 2016-07-28 | $10.98M derived: sum of 3 quarters · filed 2017-03-08 | $14.73M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2015-03-31 | $3.77M 10-Q · filed 2016-04-28 | $7.72M derived: sum of 2 quarters · filed 2017-03-08 | $11.47M derived: sum of 3 quarters · filed 2017-03-08 | $15.00M derived: sum of 4 quarters · filed 2017-03-08 | |||
| 2014-12-31 | $3.95M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $7.69M derived: sum of 2 quarters · filed 2017-03-08 | $11.22M derived: sum of 3 quarters · filed 2017-03-08 | $14.99M 10-K · filed 2017-03-08 | |||
| 2014-09-30 | $3.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $7.28M derived: sum of 2 quarters · filed 2015-10-29 | $11.05M 10-Q · filed 2015-10-29 | $11.05M 10-Q · filed 2014-11-06 | $13.89M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-06-30 | $3.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $7.30M 10-Q · filed 2015-07-30 | $7.30M 10-Q · filed 2014-07-31 | $10.15M derived: sum of 3 quarters · filed 2016-02-24 | $11.11M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-03-31 | $3.77M 10-Q · filed 2015-04-30 | $3.77M 10-Q · filed 2014-05-06 | $6.62M derived: sum of 2 quarters · filed 2016-02-24 | $7.58M derived: sum of 3 quarters · filed 2016-02-24 | $8.17M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2013-12-31 | $2.85M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $3.81M derived: sum of 2 quarters · filed 2016-02-24 | $4.40M derived: sum of 3 quarters · filed 2016-02-24 | $4.46M 10-K · filed 2016-02-24 | |||
| 2013-09-30 | $965.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $1.55M derived: sum of 2 quarters · filed 2014-11-06 | $1.61M 10-Q · filed 2014-11-06 | ||||
| 2013-06-30 | $588.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $644.45K 10-Q · filed 2014-07-31 | |||||
| 2013-03-31 | $56.01K 10-Q · filed 2014-05-06 | ||||||
| 2012-12-31 | $246.00K 10-K · filed 2015-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |